@article {Bernabe2020.11.15.20232173, author = {Beatriz Penalver Bernabe and Janet L. Cunningham and Lisa Tussing-Humphreys and Ian Carroll and Samantha Meltzer-Brody and Pauline M. Maki and Jack A. Gilbert and Mary Kimmel}, title = {A Proof of Concept for a Systems Approach to Biologically Characterize the Maternal Gut Microbiome, Immune Patterns and Mental Distress During Pregnancy}, elocation-id = {2020.11.15.20232173}, year = {2020}, doi = {10.1101/2020.11.15.20232173}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Importance Screening for anxiety and depression is important but especially difficult during pregnancy. Identification and quantification of the variation of maternal biologic dimensions during the dynamic pregnancy period, e.g. immune and microbiome profiles, have the potential to greatly improve mental heath screening and patient stratification.Objective To determine if specific immune and microbiome profiles align with features of mental distress during pregnancy.Design Prospective case-control study from two cohorts in US followed from 2017 to 2019 in the second and third trimesters.Setting For the urban cohort, recruitment from an obstetric clinic; for the suburbian group, recruitment from advertisements in the hospital and surrounding communities.Participants A total of 90 pregnant women from two distinct geographic regions, with contrasting race, age, marital status, education and urban vs suburban settings.Exposures Self-reported mental health symptoms (anxiety, preceptions of stress and depression) and sociodemographic characteristics; blood was obtained for cytokine profiles and stool for microbiota analysis.Main Outcomes and Measures Dimensionality reduction clustered the symptom scores from the three self-report tools. Phenotypes based on these features were then defined.Results Factor analysis revealed four features: Burn-out, Low Self-Esteem, Mixed State, and Suicidal/Self-Harm; six phenotypes: severe, with and without suicidal thoughts, depressed with low self-steem, hyperactive, and healthy. Factors and phenotype groups were statistically associated with immune and microbiota profiles and sociodemography. The hyperactive phenotype, despite having low self-reported symptoms, had elevated inflammatory cytokines and a microbiota profile similar to the severe phenotype. Elevated T-helper cell 17 (Th17), inducer of inflammation, is related to anxiety in these cohorts. Variance in socioeconomic factors and and the gut microbiota profile can account for 50\% of the variance in phenotype.Conclusion Better stratification of biological charateristics is essential for understanding complex perinatal mental disorders and can be achieved by including microbiota and immune data. Our preliminary results suggest that variance in microbial and immune factors can describe differences in mental health phenotype, and could be predictive of the women{\textquoteright}s current or future risk for future diagnosis. These findings form testable hypotheses for larger longitudinal studies.Question Does self-reported mental distress in late pregnancy align with specific immune and microbiome patterns?Findings We show potential limitations in sole reliance on self-reported symptoms of mental distress in 90 subjects from two prospective cohorts. The most different groups based on symptom-based factors presented statistically similar inflammation and microbiome profiles that may reflect underreporting of mental distress symptoms.Meaning A systems biology approach identified risk immune and microbiome profiles with potential advantages to augment self-report. These biological charateristics high risk for mental distress in pregnancy should be confirmed in larger cohorts and may improve understanding of perinatal mood disorders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBPB was funded by the Arnold O. Beckman Postdoctoral Award, K-12 Biomedical Interdisciplinary Research in Women{\textquoteright}s Health Award. MK is supported by the NIMH K23 Training Award (1 K23 MH110660-01) and her research was also funded through a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation and the P\&S Fund. This work has been funded by the NICHD 5R03HD095056-02. REDCap application is supported though the Center for Clinical and Translational Science (CCTS) UL1TR002003.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Study protocols were approved by the University of Illinois at Chicago, Chicago (IRB$\#$ 2014-0325, IRB$\#$2018-0842) and the University of North Carolina, Chapel Hill (IRB $\#$16-0959 and 16-2783) Institutional Review Boards.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data have been deposited in SRA BioProject PRJNA667109}, URL = {https://www.medrxiv.org/content/early/2020/11/18/2020.11.15.20232173}, eprint = {https://www.medrxiv.org/content/early/2020/11/18/2020.11.15.20232173.full.pdf}, journal = {medRxiv} }